跳转到主要内容
搜索
会议

ACCP 年度会议

Conference: ACCP 年度会议

日期： 2025 年 9 月 14 - 16 日

地点： Phoenix, Arizona

展位： #4

Certara at the 2025 ACCP Annual Meeting

We are thrilled to participate as an exhibitor at the 2025 American College of Clinical Pharmacology (ACCP) Annual Meeting, held September 14-16, 2025, at the Renaissance Phoenix Downtown Hotel, in Phoenix, Arizona.

This year’s theme, “Advancing Clinical Pharmacology to Optimize Outcomes,” resonates deeply with Certara’s mission to accelerate and enhance patient access to innovative therapies through model-informed drug development and regulatory science.

Visit us at booth #4 to engage with our scientific experts, discover our latest advancements in clinical pharmacology and pharmacometrics, and see how Certara is shaping the future of smarter, faster drug development. We’re proud to showcase our scientific leadership with a substantial presence, including expert-led presentations, scientific posters, and on-site engagement opportunities.

Where to hear Certara insights and expertise

Monday, September 15 8am – 9:30am MST
Symposium 5: Little Lives, Big Care: Navigating Complexities of Drug Dosing & Innovations in Pharmacotherapy for Preterm Infants
Presentation 2 – (Topic: To be Announced soon)

Presenters: Amy S. Cheung, PhD

Monday, September 15 9:30am - 9:50am MST
Industry Theater Presentation (Topic: to be announced soon)
Monday, September 15 8:00am – 9:30am MST
Symposium 5: Little Lives, Big Care: Navigating Complexities of Drug Dosing & Innovations in Pharmacotherapy for Preterm Infants
3 - PBPK Modeling in Preterm & Term Neonates: 案例研究

Presenters: Karen Yeo，博士

Tuesday, September 16 8:00am – 11:30am MST
Symposium 10: 模型引导的药物开发（MIDD）：Advancing Predictive Power With Biomarkers, Mechanistic Models & Artificial Intelligence/Machine Learning
7 - AI-enabled Quantitative Systems Pharmacology: Predicting Clinical Outcomes for Novel Treatments

Presenters: Piet van der Graaf, PharmD, PhD

Tuesday, September 16 8:00am – 9:30am MST
"Inclusion vs Exclusion: How Physiologically-based Pharmacokinetic Modeling Could Help DDI Management in Clinical Trials"

Presenters: Amin Rostami, PhD

Explore Certara Resources

We are committed to transforming drug development through innovative science and customer-centric solutions. Learn more about our capabilities:

  • 临床药理学: Achieve faster, data-driven clinical development decisions with our integrated strategies, from first-in-human to late-phase trials.
  • 定量药理学: Uncover actionable insights with industry-leading pharmacometric modeling and exposure-response analyses.
  • Modeling & Simulation Services: Reduce risks and speed up development with robust simulation technologies supporting evidence-based decisions throughout the lifecycle.
  • Simcyp™ PBPK Platform: Confidently predict clinical outcomes using the Simcyp™ PBPK platform for ADME evaluation, drug-drug interactions, and special population responses.
  • 定量系统药理学 (QSP): Deepen disease and drug action understanding to enhance target validation and trial design through QSP modeling.
  • Regulatory Science & Strategy: Navigate global regulatory pathways with precision via Certara’s expert-led strategies, submission support, and agency engagement services.

Join us in redefining the future of clinical pharmacology. Together, we can optimize therapeutic outcomes and create a positive impact on patient lives.

精选推荐

MIDD 可缓解日本儿科及罕见疾病药物短缺问题
博客

MIDD 可缓解日本儿科及罕见疾病药物短缺问题

通过项目管理服务加速肿瘤药物 FDA 申报流程
案例研究

通过项目管理服务加速肿瘤药物 FDA 申报流程

如何通过模型引导的药物开发助力项目从高风险局面中脱困
案例研究

如何通过模型引导的药物开发助力项目从高风险局面中脱困

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software